Sign in
4

Changes in Ownership

Acumen Pharmaceuticals, Inc. Filed Acc 0001209191-21-044947

Options or other derivatives

  • Director acquired 34,000 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Derivatives
Fountain Nathan B Director 2021-06-30 Grant or award · Stock Option (Right to Buy) +34,000 34,000 D
Loading xslF345X03/doc4.xml…